A Survey of Clinician‐Reported Management of Hypernatremia in the ICU
Acta Anaesthesiologica Scandinavica · 2027-01 · 71 (1)
DOI: 10.1111/aas.70386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 04.11.2026. Verfasst von Hans Eric Sebastian Seitz-Rasmussen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Copenhagen University Hospital - North Zealand Hospital, Hilleroed, Denmark. Hauptthemen laut MEDLINE: Hypernatremia, Intensive Care Units, Critical Care, Practice Patterns, Physicians'. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nordsjællands Hospital.
Abstract (Originalsprache)
Background
Hypernatremia is frequent in the intensive care unit (ICU) and is associated with adverse outcomes. Despite its prevalence, robust evidence to guide treatment is lacking, and global practice patterns are largely unknown. We investigated global treatment preferences and clinicians' willingness to enroll patients in a randomized trial to inform its feasibility.
Methods
This international cross‐sectional online survey comprised 20 primarily closed‐ended questions, using five‐point Likert‐scale responses, across four themes: treatment method, threshold, correction rate, and opinion on a proposed trial. Respondents considered a clinical vignette of hypernatremia developing before or during ICU admission, excluding dehydration and chronic causes. It was distributed to ICU physicians worldwide.
Results
The survey was sent to 3053 ICU physicians in 17 countries, with 1051 respondents, yielding a response rate of 34%. Of respondents, 74% were consultants, and 26% were residents. The mean ICU experience was 14 years. Increasing free water intake via enteral route was the most frequently reported treatment strategy (80% reporting “often” or “always”). Moderate hypernatremia (plasma sodium 151–156 mmol/L) was the most frequently reported threshold for initiating correction (533/892, 60%). 45% (396/888) preferred a correction rate of 8–12 mmol/L/day, and 41% (366/888) of < 8 mmol/L/day, with the remainder having no correction rate target or correction rate target of > 12 mmol/L/day. 74% (654/882) reported no barriers to enrolling eligible patients in the proposed trial.
Conclusion
Among ICU physicians, correction of hypernatremia is mostly achieved by increasing free water intake using hypotonic fluids, predominantly via the enteral route. Most clinicians initiate treatment once hypernatremia reaches a moderate level, aiming for a correction rate of < 12 mmol/L/day. Most clinicians expressed willingness to enroll eligible patients in the proposed trial. Editorial Comment This survey study aimed to sample physician preferences for treatment of hypernatremia when on their way to or in the ICU. This study sampled respondents in many countries, and based on different phases of treatment and assessment, as well as participant willingness for a future treatment trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, Copenhagen University Hospital - North Zealand Hospital, Hilleroed, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Anesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Anaesthesia and Intensive Care, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, England, UK.
- Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK.
ORCID-Profile: Hans Eric Sebastian Seitz-Rasmussen, Morten H Bestle, Olav Lilleholt Schjørring, Andrew Ratcliffe, Jonathan Silversides, Peter Bentzer, Pedro Povoa, Johanna Hästbacka, Kristian Strand, Paul Young, Niels Van Regenmortel, Carmen A Pfortmüller, Manu L N G Malbrain, Meint Volbeda, Sine Wichmann
Förderung
- Nordsjællands Hospital
Zitieren
APA
Seitz-Rasmussen, H. E. S., Bestle, M. H., Schjørring, O. L., Ratcliffe, A., O'Grady, A., Silversides, J., Broman, M., Bentzer, P., Povoa, P., Hästbacka, J., Strand, K., Young, P., Van Regenmortel, N., Pfortmüller, C. A., Malbrain, M. L. N. G., Nasser, A., Sigurdson, M., Volbeda, M., Wichmann, S., & SALT‐ICU Survey (2027). A Survey of Clinician‐Reported Management of Hypernatremia in the ICU. Acta Anaesthesiologica Scandinavica, 71(1). https://doi.org/10.1111/aas.70386
Vancouver
Seitz-Rasmussen HES, Bestle MH, Schjørring OL, Ratcliffe A, O'Grady A, Silversides J, et al. A Survey of Clinician‐Reported Management of Hypernatremia in the ICU. Acta Anaesthesiologica Scandinavica. 2027;71(1). doi:10.1111/aas.70386
BibTeX
@article{SeitzRasmussen2027,
author = {Seitz-Rasmussen, Hans Eric Sebastian and Bestle, Morten H and Schjørring, Olav Lilleholt and Ratcliffe, Andrew and O'Grady, Aoife and Silversides, Jonathan and Broman, Marcus and Bentzer, Peter and Povoa, Pedro and Hästbacka, Johanna and Strand, Kristian and Young, Paul and Van Regenmortel, Niels and Pfortmüller, Carmen A and Malbrain, Manu L N G and Nasser, Ahmad and Sigurdson, Martin and Volbeda, Meint and Wichmann, Sine and SALT‐ICU Survey, SALT‐ICU Survey},
title = {A Survey of Clinician‐Reported Management of Hypernatremia in the ICU},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2027},
volume = {71},
number = {1},
doi = {10.1111/aas.70386}
}
EUVIMED